We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Boston Scientific Stock Down Following Warning Letter; May Compromise Guidant Deal
Boston Scientific Stock Down Following Warning Letter; May Compromise Guidant Deal
February 3, 2006
On the heels of receiving an FDA warning letter, Boston Scientific’s stock continues to fall and the Guidant deal may not be as solid as it was believed to be.